AKT1 and acute myeloid leukemia: A study conducted by Qin and colleagues demonstrated that SNX-2112, belonging to the second generation of HSP90 inhibitors, inhibited cell proliferation and promoted differentiation, G2/M cell cycle arrest and apoptotic cell death in human AML cells via AKT and NF-κB inhibition.